OCULAR THERAPEUTIX, INC Operating Leases, Future Minimum Payments, Due in Three Years
OCULAR THERAPEUTIX, INC (OCUL) had Operating Leases, Future Minimum Payments, Due in Three Years of $1.89 million as of 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears · last filed 2020-03-12
- 2019-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $1.89M.
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $1.89M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $1.85M.
- 2017-09-30: Operating Leases, Future Minimum Payments, Due in Three Years $1.24M.
| Period end | Operating Leases, Future Minimum Payments, Due in Three Years |
|---|---|
| 2019-12-31 | $1.89M 10-K · filed 2020-03-12 |
| 2018-12-31 | $1.89M 10-Q · filed 2019-11-12 |
| 2017-12-31 | $1.85M 10-K · filed 2018-03-08 |
| 2017-09-30 | $1.24M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $1.24M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $1.24M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $1.24M 10-K · filed 2017-03-10 |
| 2016-03-31 | $262.00K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $262.00K 10-K · filed 2016-03-10 |
| 2015-09-30 | $676.00K 10-Q · filed 2015-11-10 |
| 2015-06-30 | $676.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $676.00K 10-Q · filed 2015-05-15 |
| 2014-12-31 | $676.00K 10-K · filed 2015-03-20 |
| 2014-09-30 | $820.00K 10-Q · filed 2014-11-12 |
| 2014-06-30 | $820.00K 10-Q · filed 2014-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |